However, its combination with DOX at a molar ratio of 5: 1 (5IOX1 + DOX) effectively inhibited the tumour growth (Fig. 2a), even significantly better than DOX combination with anti-PD-L1 antibody (αPD-L1). Here, CD274 is linked to neoplasm.